These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1523283)

  • 21. 5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice.
    Reith ME
    Eur J Pharmacol; 1990 Sep; 186(2-3):327-30. PubMed ID: 2289534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of [14C]guanidinium accumulation in NG 108-15 cells exposed to serotonin 5-HT3 receptor ligands and substance P.
    Emerit MB; Riad M; Fattaccini CM; Hamon M
    J Neurochem; 1993 Jun; 60(6):2059-67. PubMed ID: 7684066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. R-zacopride, a 5-HT3 antagonist/5-HT4 agonist, reduces sleep apneas in rats.
    Carley DW; Depoortere H; Radulovacki M
    Pharmacol Biochem Behav; 2001; 69(1-2):283-9. PubMed ID: 11420096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central action of 5-HT3 receptor ligands in the regulation of sleep-wakefulness and raphe neuronal activity in the rat.
    Adrien J; Tissier MH; Lanfumey L; Haj-Dahmane S; Jolas T; Franc B; Hamon M
    Neuropharmacology; 1992 Jun; 31(6):519-29. PubMed ID: 1407392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells.
    Bolaños FJ; Schechter LE; Miquel MC; Emerit MB; Rumigny JF; Hamon M; Gozlan H
    Biochem Pharmacol; 1990 Oct; 40(7):1541-50. PubMed ID: 2222509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety.
    Andrews N; File SE
    Eur J Pharmacol; 1993 Apr; 235(1):109-12. PubMed ID: 8519271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of tryptophan residue(s) in the specific binding of agonists/antagonists to 5-HT3 receptors in NG108-15 clonal cells.
    Miquel MC; Emerit MB; Gozlan H; Hamon M
    Biochem Pharmacol; 1991 Sep; 42(7):1453-61. PubMed ID: 1930269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zacopride, a potent 5-HT3 antagonist.
    Smith WW; Sancilio LF; Owera-Atepo JB; Naylor RJ; Lambert L
    J Pharm Pharmacol; 1988 Apr; 40(4):301-2. PubMed ID: 2900319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zacopride and its optical isomers produce stereoselective antagonism of a 2-methylserotonin discriminative stimulus.
    Young R; Glennon RA
    Eur J Pharmacol; 1992 Feb; 212(1):117-9. PubMed ID: 1555633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.
    Barnes JM; Barnes NM
    Biochem Pharmacol; 1993 May; 45(10):2155-8. PubMed ID: 8390263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues.
    Kidd FJ; Levy JC; Nielsen M; Hamon M; Gozlan H
    Eur J Pharmacol; 1993 Sep; 247(1):45-56. PubMed ID: 8258360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-HT3 receptor antagonists attenuate dopamine-induced hyperactivity in the rat.
    Costall B; Domeney AM; Naylor RJ
    Neuroreport; 1990 Sep; 1(1):77-80. PubMed ID: 1966601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of effects of 5HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat.
    File SE; Johnston AL
    Psychopharmacology (Berl); 1989; 99(2):248-51. PubMed ID: 2552485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-HT3 receptor antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism.
    Svingos AL; Hitzemann R
    Pharmacol Biochem Behav; 1992 Nov; 43(3):871-9. PubMed ID: 1448481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potent 5-HT3 receptor antagonist (R)-zacopride labels an additional high affinity site in the central nervous system.
    Kidd E; Bouchelet de Vendegies I; Levy JC; Hamon M; Gozlan H
    Eur J Pharmacol; 1992 Jan; 211(1):133-6. PubMed ID: 1618262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [3H]zacopride: ligand for the identification of 5-HT3 recognition sites.
    Barnes NM; Costall B; Naylor RJ
    J Pharm Pharmacol; 1988 Aug; 40(8):548-51. PubMed ID: 2907008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zacopride, a 5-HT3 receptor antagonist, reduces voluntary ethanol consumption in rats.
    Knapp DJ; Pohorecky LA
    Pharmacol Biochem Behav; 1992 Apr; 41(4):847-50. PubMed ID: 1594653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioural evidence.
    Andrews N; File SE
    Psychopharmacology (Berl); 1993; 112(1):21-5. PubMed ID: 7871006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LY277359 maleate: a potent and selective 5-HT3 receptor antagonist without gastroprokinetic activity.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1990 Jul; 254(1):350-5. PubMed ID: 2366187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT(1A) receptor antagonists.
    Griebel G; Rodgers RJ; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1999 May; 144(2):121-30. PubMed ID: 10394992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.